Limits...
Efficacy and safety of a 24-day regimen of drospirenone-containing combined oral contraceptive in Korean women.

Kim N, Yoo HN, Hyun HS, Lee DY, Yoon BK, Choi DS - Obstet Gynecol Sci (2015)

Bottom Line: This study assesses the efficacy and safety of a 24-day regimen of drospirenone-containing combined oral contraceptive, and demonstrates that it is an effective and safe option for contraception, releasing symptom of premenstrual dysphoric disorder and acne in Korean women.

View Article: PubMed Central - PubMed

Affiliation: Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

ABSTRACT
This study assesses the efficacy and safety of a 24-day regimen of drospirenone-containing combined oral contraceptive, and demonstrates that it is an effective and safe option for contraception, releasing symptom of premenstrual dysphoric disorder and acne in Korean women.

No MeSH data available.


Related in: MedlinePlus

(A) Efficacy of Yaz for non-contraceptive benefits. (B) Compliance of Yaz by indication. PMDD, premenstrual dysphoric disorder.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4588845&req=5

Figure 1: (A) Efficacy of Yaz for non-contraceptive benefits. (B) Compliance of Yaz by indication. PMDD, premenstrual dysphoric disorder.

Mentions: During the study period, no pregnancy was reported. Efficacy for PMDD and acne treatment, which were classified into four categories by the study participants, were evaluated (Fig. 1A). For PMDD, proportions of 'much better' (32.5%) and 'better' (59.8%) were higher than those of 'no change' or 'worse.' Similar effects were also shown for acne, showing 'much better' in 26.7% and 'better' in 56.0% (Fig. 1A). In the analysis of factors affecting efficacy and effectiveness rate, duration of use was significantly associated positively with PMDD improvement (P<0.001, data not shown).


Efficacy and safety of a 24-day regimen of drospirenone-containing combined oral contraceptive in Korean women.

Kim N, Yoo HN, Hyun HS, Lee DY, Yoon BK, Choi DS - Obstet Gynecol Sci (2015)

(A) Efficacy of Yaz for non-contraceptive benefits. (B) Compliance of Yaz by indication. PMDD, premenstrual dysphoric disorder.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4588845&req=5

Figure 1: (A) Efficacy of Yaz for non-contraceptive benefits. (B) Compliance of Yaz by indication. PMDD, premenstrual dysphoric disorder.
Mentions: During the study period, no pregnancy was reported. Efficacy for PMDD and acne treatment, which were classified into four categories by the study participants, were evaluated (Fig. 1A). For PMDD, proportions of 'much better' (32.5%) and 'better' (59.8%) were higher than those of 'no change' or 'worse.' Similar effects were also shown for acne, showing 'much better' in 26.7% and 'better' in 56.0% (Fig. 1A). In the analysis of factors affecting efficacy and effectiveness rate, duration of use was significantly associated positively with PMDD improvement (P<0.001, data not shown).

Bottom Line: This study assesses the efficacy and safety of a 24-day regimen of drospirenone-containing combined oral contraceptive, and demonstrates that it is an effective and safe option for contraception, releasing symptom of premenstrual dysphoric disorder and acne in Korean women.

View Article: PubMed Central - PubMed

Affiliation: Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

ABSTRACT
This study assesses the efficacy and safety of a 24-day regimen of drospirenone-containing combined oral contraceptive, and demonstrates that it is an effective and safe option for contraception, releasing symptom of premenstrual dysphoric disorder and acne in Korean women.

No MeSH data available.


Related in: MedlinePlus